Rita Shaknovich
Keine laufenden Positionen mehr
Profil
Rita Shaknovich served as the Chief Medical Officer & Group Medical Director at Cancer Genetics, Inc. from 2017 to 2018.
She is a graduate of the Icahn School of Medicine at Mount Sinai.
Ehemalige bekannte Positionen von Rita Shaknovich
| Unternehmen | Position | Ende |
|---|---|---|
| CANCER GENETICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 12.09.2018 |
Ausbildung von Rita Shaknovich
| Icahn School of Medicine at Mount Sinai | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Cancer Genetics, Inc.
 Cancer Genetics, Inc. Medical SpecialtiesHealth Technology Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomarker solutions, bio repository solutions, consulting, cytogenetic testing, nucleic acid extraction and purification, flow cytometry, Focus: NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ. | Health Technology |
